RIEFLIN WILLIAM JL
Insider CIK 1182471 · XNPT Director · ANAC Director · NGM Executive Chairman, Director · RAPT Director · LYCA Director · LYEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYCA Lycia Therapeutics, Inc. | A Award deriv | 2026-10-22 | 2026-10-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LYCA Lycia Therapeutics, Inc. | A Award deriv | 2026-08-11 | 2026-10-26 | 24,840 | — | $0 | 24,840 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 9,250 | — | $0 | 9,250 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2025-05-15 | 2025-05-19 | 130,000 | — | $0 | 130,000 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 130,000 | — | $0 | 130,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2024-05-23 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 80,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 78,407 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 225,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 50,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 80,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 75,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | U Tender | 2024-04-05 | 2024-04-08 | 5,172 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | U Tender | 2024-04-05 | 2024-04-08 | 2,769,168 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2024-03-28 | 2024-04-01 | 11,871 | $7.58 | $90.0K | 11,871 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2023-09-08 | 2023-09-08 | 55,000 | — | $0 | 55,000 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2023-06-16 | 2023-06-20 | 65,000 | — | $0 | 65,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-05-10 | 2023-05-12 | 78,407 | — | $0 | 78,407 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2023-03-31 | 2023-04-10 | 6,026 | $14.52 | $87.5K | 6,026 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 65,000 | — | $0 | 65,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 5,207 | $16.80 | $87.5K | 5,207 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2022-03-03 | 2022-03-04 | 80,000 | — | $0 | 80,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2021-05-28 | 2021-06-24 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2021-03-17 | 2021-03-18 | 80,000 | — | $0 | 80,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | P Buy | 2020-11-19 | 2020-11-20 | 10,000 | $16.22 | $162.2K | 18,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2020-02-04 | 2020-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 260,344 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 100,000 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 16,666 | — | $0 | 76,722 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | P Buy | 2019-11-04 | 2019-11-04 | 8,000 | $12.00 | $96.0K | 8,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 43,390 | — | $0 | 60,056 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2019-10-30 | 2019-11-01 | 3,333 | — | $0 | 3,333 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2019-10-30 | 2019-11-01 | 15,334 | — | $0 | 15,334 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | C Conversion deriv | 2019-04-08 | 2019-04-10 | 50,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | C Conversion deriv | 2019-04-08 | 2019-04-10 | 6,668 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | C Conversion | 2019-04-08 | 2019-04-10 | 56,668 | — | $0 | 2,769,168 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 25,000 | $7.03 | $175.8K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 5,000 | $7.03 | $35.1K | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 68 | $7.03 | $478 | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 281,117 | $7.03 | $1.98M | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 31,660 | $7.03 | $222.6K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,403 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer | 2016-06-24 | 2016-06-24 | 89,000 | $99.25 | $8.83M | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer | 2016-06-24 | 2016-06-24 | 853 | $99.25 | $84.7K | 0 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2016-05-17 | 2016-05-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 31,660 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2016-03-31 | 2016-04-04 | 30,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2016-03-31 | 2016-04-04 | 24,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2016-03-31 | 2016-04-04 | 7,500 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2016-03-31 | 2016-04-04 | 12,500 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2016-03-31 | 2016-04-04 | 15,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2016-03-31 | 2016-04-04 | 24,000 | $14.22 | $341.3K | 89,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2016-03-31 | 2016-04-04 | 12,500 | $5.20 | $65.0K | 50,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2016-03-31 | 2016-04-04 | 15,000 | $5.11 | $76.7K | 65,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2016-03-31 | 2016-04-04 | 7,500 | $6.74 | $50.5K | 37,500 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2016-03-31 | 2016-04-04 | 30,000 | $6.92 | $207.6K | 30,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-06-09 | 2015-06-11 | 4,403 | — | $0 | 4,403 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-06-09 | 2015-06-11 | 853 | — | $0 | 853 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2015-05-19 | 2015-05-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 26,660 | SEC↗ |
| XNPT XENOPORT INC | S Sale | 2014-12-10 | 2014-12-12 | 2,918 | $8.49 | $24.8K | 29,752 | SEC↗ |
| XNPT XENOPORT INC | S Sale | 2014-12-10 | 2014-12-12 | 5,592 | $8.49 | $47.5K | 24,160 | SEC↗ |
| XNPT XENOPORT INC | S Sale | 2014-12-10 | 2014-12-12 | 2,500 | $8.49 | $21.2K | 21,660 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2014-06-17 | 2014-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2014-06-11 | 2014-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-05-29 | 2014-05-30 | 24,000 | — | $0 | 24,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2014-05-14 | 2014-05-16 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2014-05-14 | 2014-05-16 | 5,000 | — | $0 | 32,670 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-06-06 | 2013-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2013-05-16 | 2013-05-16 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2013-05-16 | 2013-05-16 | 5,000 | — | $0 | 27,670 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2013-05-14 | 2013-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2013-05-14 | 2013-05-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-05-30 | 2012-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2012-05-16 | 2012-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2012-05-16 | 2012-05-17 | 5,000 | — | $0 | 5,000 | SEC↗ |